Click here for a PDF of the release.
Click here for 3Q09 Supplemental Information.
“In the face of the significant challenges of 2009, we successfully disposed of non-core assets and will have completed over
“At the same time, we strengthened our balance sheet this year. We raised
Recent Highlights.
- Completed 3Q09 and year-to-date gross new investments totaling
$156.3 million and$507.7 million , respectively - Received
$177.4 million in proceeds on property sales and loan payoffs year-to-date, generating$26.9 million of gains - Raised
$434.6 million of net equity proceeds during 3Q09 through our September offering, equity shelf program and dividend reinvestment program - Raised
$132.5 million ofFreddie Mac mortgage loans during 3Q09 with an average rate of 5.9% - Prepaid
$58.8 million of secured debt in September with a blended rate of 7.2% - Repurchased
$161.4 million of outstanding 8.0% unsecured 2012 senior notes in September
Key Performance Indicators.
3Q09 | 3Q08 | Change | 2009 | 2008 | Change | ||||||||
Net income attributable to common stockholders (NICS) |
$0.17 | $0.55 | -69% | $1.25 | $2.61 | -52% | |||||||
Normalized FFO per diluted share | $0.77 | $0.86 | -10% | $2.38 | $2.51 | -5% | |||||||
Normalized FAD per diluted share | $0.72 | $0.82 | -12% | $2.24 | $2.39 | -6% | |||||||
Dividends per common share | $0.68 | $0.68 | 0% | $2.04 | $2.02 | 1% | |||||||
Normalized FFO Payout Ratio | 88% | 79% | 86% | 80% | |||||||||
Normalized FAD Payout Ratio | 94% | 83% | 91% | 85% | |||||||||
3Q09 Earnings. The following table summarizes certain items impacting NICS, FFO and FAD:
NICS | FFO | FAD | ||||||||||||
3Q09 | 3Q08 | Change | 3Q09 | 3Q08 | Change | 3Q09 | 3Q08 | Change | ||||||
Per diluted share | $0.17 | $0.55 | -69% | $0.53 | $0.85 | -38% | $0.55 | $0.86 | -36% | |||||
Includes impact of: | ||||||||||||||
Gain (loss) on sales of real property (1) |
($0.01) | $0.13 | ||||||||||||
Other items, net (2) | ($0.25) | ($0.01) | ($0.25) | ($0.01) | ($0.25) | ($0.01) | ||||||||
Prepaid/straight-line rent cash receipts (3) | $0.07 | $0.05 | ||||||||||||
Per diluted share - normalized (a) | $0.77 | $0.86 | -10% | $0.72 | $0.82 | -12% |
(a) | Amounts may not sum due to rounding | |||
(1) | $806,000 of losses and $12,619,000 of gains in 3Q09 and 3Q08, respectively. | |||
(2) | See FFO and FAD reconciliation exhibits for other items. | |||
(3) | $8,319,000 and $4,781,000 of receipts in 3Q09 and 3Q08, respectively. | |||
2009 Year-To-Date Earnings. The following table summarizes certain items impacting NICS, FFO and FAD:
NICS | FFO | FAD | ||||||||||||
2009 | 2008 | Change | 2009 | 2008 | Change | 2009 | 2008 | Change | ||||||
Per diluted share | $1.25 | $2.61 | -52% | $2.11 | $2.50 | -16% | $2.17 | $2.55 | -15% | |||||
Includes impact of: | ||||||||||||||
Gain on sales of real property (1) |
$0.24 | $1.44 | ||||||||||||
Other items, net (2) | ($0.27) | ($0.01) | ($0.27) | ($0.01) | ($0.27) | ($0.01) | ||||||||
Prepaid/straight-line rent cash receipts (3) | $0.21 | $0.17 | ||||||||||||
Per diluted share - normalized (a) | $2.38 | $2.51 | -5% | $2.24 | $2.39 | -6% |
(a) | Amounts may not sum due to rounding | |||
(1) |
$26,907,000 and $130,813,000 of gains in 2009 and 2008, respectively. |
|||
(2) | See FFO and FAD reconciliation exhibits for other items. | |||
(3) | $23,463,000 and $15,679,000 of receipts in 2009 and 2008, respectively. | |||
Non-recurring Third Quarter 2009 Items. The following items impacted 2009 earnings:
$20.9 million of loss on extinguishment of debt ($0.18 per diluted share) was recognized in connection with the company’s repurchase of$161.4 million of outstanding 8.0% unsecured senior notes due 2012.$5.4 million of loss on extinguishment of debt ($0.05 per diluted share) was recognized in connection with the company’s prepayment of$58.8 million of secured debt with a blended interest rate of 7.2%.$1.9 million of impairment charges ($0.02 per diluted share) were recognized in connection with the four remaining medical office buildings classified as held-for-sale to adjust for current sales price expectations.$0.8 million of losses ($0.01 per diluted share) were recognized in connection with the sales of ten medical office buildings previously classified as held-for-sale.
Dividends for Third Quarter 2009. As previously announced, the Board of Directors declared a cash dividend for the quarter ended
Outlook for 2009. The company is revising its 2009 guidance to reflect current expectations for the remainder of the year.
- Investments: There are no acquisitions in our current assumptions. Funded new development expectations have been decreased to
$550 million from$600 million and dispositions have been revised to$250 million from a range of$200 to$300 million . As a result, net investment guidance has been revised to$300 million from a range of$300 to $400 million . - Capital: During the third quarter of 2009, the company issued
$434.6 million of new equity, raised$132.5 million of new secured debt, prepaid$58.8 million of outstanding secured debt and repurchased$161.4 million of outstanding unsecured senior notes. In addition to this activity, the company does not anticipate raising any additional secured debt in 2009. - Earnings: The company is narrowing its normalized FFO and FAD guidance to reflect actual year-to-date results as well as revised investment and capital expectations described above. Normalized FFO has been revised to a range of
$3.10 to $3.12 per diluted share from$3.07 to $3.14 per diluted share. Normalized FAD has been revised to a range of$2.92 to$2.94 per diluted share from$2.91 to $2.98 per diluted share. Net income attributable to common stockholders has been decreased to a range of$1.61 to $1.63 per diluted share from$1.75 to $1.82 per diluted share. The prior net income guidance included$5 million of debt extinguishment charges for the secured debt prepayments. The decrease in net income guidance is primarily due to the additional$20.9 million debt extinguishment charge recognized in the third quarter in connection with the company’s unsecured senior notes tender offer.
The company’s guidance excludes any additional capital transactions, impairments, unanticipated additions to the loan loss reserve or other additional one-time items, including any additional cash payments other than normal monthly rental payments. Please see the exhibits for a reconciliation of the outlook for net income available to common stockholders to normalized FFO and FAD.
Conference Call Information. The company has scheduled a conference call on
Supplemental Reporting Measures. The company believes that net income attributable to common stockholders (NICS), as defined by U.S. generally accepted accounting principles (U.S. GAAP), is the most appropriate earnings measurement. However, the company considers funds from operations (FFO) and funds available for distribution (FAD) to be useful supplemental measures of its operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the
The company’s supplemental reporting measures and similarly entitled financial measures are widely used by investors and equity analysts in the valuation, comparison and investment recommendations of companies. The company’s management uses these financial measures to facilitate internal and external comparisons to historical operating results and in making operating decisions. Additionally, they are utilized by the Board of Directors to evaluate management. The supplemental reporting measures do not represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the supplemental reporting measures, as defined by the company, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies. Please see the exhibits for reconciliations of the supplemental reporting measures.
About
This document may contain “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements concern and are based upon, among other things, the possible expansion of the company’s portfolio; the sale of properties; the performance of its operators/tenants and properties; its occupancy rates; its ability to acquire, develop and/or manage properties; its ability to enter into agreements with viable new tenants for vacant space or for properties that the company takes back from financially troubled tenants, if any; its ability to make distributions to stockholders; its policies and plans regarding investments, financings and other matters; its tax status as a real estate investment trust; its ability to appropriately balance the use of debt and equity; its ability to access capital markets or other sources of funds; its critical accounting policies; and its ability to meet its earnings guidance. When the company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. The company’s expected results may not be achieved, and actual results may differ materially from expectations. This may be a result of various factors, including, but not limited to: the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators’/tenants’ difficulty in cost-effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and senior housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; the company’s ability to transition or sell facilities with profitable results; the failure to make new investments as and when anticipated; acts of God affecting the company’s properties; the company’s ability to re-lease space at similar rates as vacancies occur; the company’s ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant bankruptcies or insolvencies; government regulations affecting
HEALTH CARE REIT, INC. Financial Exhibits |
|||||||||||
CONSOLIDATED BALANCE SHEETS (unaudited) | |||||||||||
(In thousands) | |||||||||||
September 30, | |||||||||||
2009 | 2008 | ||||||||||
Assets | |||||||||||
Real estate investments: | |||||||||||
Real property owned: | |||||||||||
Land and land improvements | $ | 523,107 | $ | 506,083 | |||||||
Buildings and improvements | 4,933,561 | 4,649,491 | |||||||||
Acquired lease intangibles | 121,059 | 136,603 | |||||||||
Real property held for sale, net of accumulated depreciation | 37,118 | 41,336 | |||||||||
Construction in progress | 638,507 | 497,673 | |||||||||
6,253,352 | 5,831,186 | ||||||||||
Less accumulated depreciation and intangible amortization | (664,415 | ) | (569,363 | ) | |||||||
Net real property owned | 5,588,937 | 5,261,823 | |||||||||
Real estate loans receivable: | |||||||||||
Loans receivable | 494,877 | 501,871 | |||||||||
Less allowance for losses on loans receivable | (7,640 | ) | (7,406 | ) | |||||||
Net real estate loans receivable | 487,237 | 494,465 | |||||||||
Net real estate investments | 6,076,174 | 5,756,288 | |||||||||
Other assets: | |||||||||||
Equity investments | 3,020 | 1,862 | |||||||||
Deferred loan expenses | 24,755 | 25,315 | |||||||||
Cash and cash equivalents | 102,353 | 18,273 | |||||||||
Restricted cash | 17,493 | 83,189 | |||||||||
Receivables and other assets | 157,611 | 137,028 | |||||||||
305,232 | 265,667 | ||||||||||
Total assets | $ | 6,381,406 | $ | 6,021,955 | |||||||
Liabilities and equity | |||||||||||
Liabilities: | |||||||||||
Borrowings under unsecured lines of credit arrangements | $ | 143,000 | $ | 387,000 | |||||||
Senior unsecured notes | 1,651,916 | 1,830,102 | |||||||||
Secured debt | 625,571 | 452,054 | |||||||||
Accrued expenses and other liabilities | 124,769 | 124,986 | |||||||||
Total liabilities | 2,545,256 | 2,794,142 | |||||||||
Equity: | |||||||||||
Preferred stock | 288,683 | 301,901 | |||||||||
Common stock | 122,870 | 103,110 | |||||||||
Capital in excess of par value | 3,878,872 | 3,147,807 | |||||||||
Treasury stock | (7,619 | ) | (5,145 | ) | |||||||
Cumulative net income | 1,510,449 | 1,327,009 | |||||||||
Cumulative dividends | (1,968,336 | ) | (1,647,699 | ) | |||||||
Accumulated other comprehensive income | (4,942 | ) | (11,905 | ) | |||||||
Other equity | 5,551 | 3,777 | |||||||||
Total Health Care REIT, Inc. stockholders’ equity | 3,825,528 | 3,218,855 | |||||||||
Noncontrolling interests | 10,622 | 8,958 | |||||||||
Total equity | 3,836,150 | 3,227,813 | |||||||||
Total liabilities and equity | $ | 6,381,406 | $ | 6,021,955 | |||||||
CONSOLIDATED STATEMENTS OF INCOME (unaudited) | |||||||||||||||
(In thousands, except per share data) | |||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||
September 30, | September 30, | ||||||||||||||
2009 | 2008 | 2009 | 2008 | ||||||||||||
Revenues: | |||||||||||||||
Rental income | $ | 133,481 | $ | 126,384 | $ | 393,901 | $ | 357,588 | |||||||
Interest income | 10,528 | 10,910 | 30,639 | 29,177 | |||||||||||
Other income | 1,089 | 2,055 | 3,810 | 5,655 | |||||||||||
Gross revenues | 145,098 | 139,349 | 428,350 | 392,420 | |||||||||||
Expenses: | |||||||||||||||
Interest expense | 28,571 | 33,725 | 82,512 | 101,569 | |||||||||||
Property operating expenses | 12,433 | 11,192 | 35,377 | 32,600 | |||||||||||
Depreciation and amortization | 41,085 | 39,011 | 120,129 | 109,649 | |||||||||||
General and administrative expenses | 10,363 | 10,789 | 38,784 | 33,693 | |||||||||||
Realized loss on derivatives | 0 | 1,513 | 0 | 1,513 | |||||||||||
Loss (gain) on extinguishment of debt | 26,374 | (768 | ) | 24,697 | (2,094 | ) | |||||||||
Provision for loan losses | 0 | 0 | 140 | 0 | |||||||||||
Total expenses | 118,826 | 95,462 | 301,639 | 276,930 | |||||||||||
Income from continuing operations before income taxes | 26,272 | 43,887 | 126,711 | 115,490 | |||||||||||
Income tax expense | 55 | 153 | (17 | ) | (1,170 | ) | |||||||||
Income from continuing operations | 26,327 | 44,040 | 126,694 | 114,320 | |||||||||||
Discontinued operations: | |||||||||||||||
Gain (loss) on sales of properties | (806 | ) | 12,619 | 26,907 | 130,813 | ||||||||||
Impairment of assets | (1,873 | ) | 0 | (1,873 | ) | 0 | |||||||||
Income from discontinued operations, net | 1,037 | 2,661 | 4,361 | 10,903 | |||||||||||
(1,642 | ) | 15,280 | 29,395 | 141,716 | |||||||||||
Net income | 24,685 | 59,320 | 156,089 | 256,036 | |||||||||||
Less: Preferred dividends |
5,520 | 5,730 | 16,560 | 17,660 | |||||||||||
Net income attributable to noncontrolling interests |
35 | 1 | 40 | 128 | |||||||||||
Net income attributable to common stockholders | $ | 19,130 | $ | 53,589 | $ | 139,489 | $ | 238,248 | |||||||
Average number of common shares outstanding: | |||||||||||||||
Basic | 114,874 | 96,040 | 111,345 | 90,500 | |||||||||||
Diluted | 115,289 | 96,849 | 111,749 | 91,121 | |||||||||||
Net income attributable to common stockholders per share: | |||||||||||||||
Basic | $ | 0.17 | $ | 0.56 | $ | 1.25 | $ | 2.63 | |||||||
Diluted | 0.17 | 0.55 | 1.25 | 2.61 | |||||||||||
Common dividends per share | $ | 0.68 | $ | 0.68 | $ | 2.04 | $ | 2.02 | |||||||
Funds From Operations Reconciliation |
|||||||||||||||||
(Amounts in 000's except per share data) | |||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
2009 | 2008 | 2009 | 2008 | ||||||||||||||
Net income attributable to common stockholders | $ | 19,130 | $ | 53,589 | $ | 139,489 | $ | 238,248 | |||||||||
Depreciation and amortization (1) | 41,085 | 41,690 | 123,143 | 120,894 | |||||||||||||
Loss (gain) on sales of properties | 806 | (12,619 | ) | (26,907 | ) | (130,813 | ) | ||||||||||
Noncontrolling interests | (88 | ) | (87 | ) | (262 | ) | (261 | ) | |||||||||
Funds from operations | 60,933 | 82,573 | 235,463 | 228,068 | |||||||||||||
Impairment of assets | 1,873 | 0 | 1,873 | 0 | |||||||||||||
Realized loss on derivatives | 0 | 1,513 | 0 | 1,513 | |||||||||||||
Non-recurring G&A expenses | 0 | 0 | 3,909 | 0 | |||||||||||||
Loss (gain) on extinguishment of debt | 26,374 | (768 | ) | 24,697 | (2,094 | ) | |||||||||||
Provision for loan losses | 0 | 0 | 140 | 0 | |||||||||||||
Non-recurring income tax expense | 0 | 0 | 0 | 1,325 | |||||||||||||
Funds from operations - normalized | $ | 89,180 | $ | 83,318 | $ | 266,082 | $ | 228,812 | |||||||||
Average common shares outstanding: | |||||||||||||||||
Basic | 114,874 | 96,040 | 111,345 | 90,500 | |||||||||||||
Diluted | 115,289 | 96,849 | 111,749 | 91,121 | |||||||||||||
Per share data: | |||||||||||||||||
Net income attributable to common stockholders | |||||||||||||||||
Basic | $ | 0.17 | $ | 0.56 | $ | 1.25 | $ | 2.63 | |||||||||
Diluted | 0.17 | 0.55 | 1.25 | 2.61 | |||||||||||||
Funds from operations | |||||||||||||||||
Basic | $ | 0.53 | $ | 0.86 | $ | 2.11 | $ | 2.52 | |||||||||
Diluted | 0.53 | 0.85 | 2.11 | 2.50 | |||||||||||||
Funds from operations - normalized | |||||||||||||||||
Basic | $ | 0.78 | $ | 0.87 | $ | 2.39 | $ | 2.53 | |||||||||
Diluted | 0.77 | 0.86 | 2.38 | 2.51 | |||||||||||||
FFO Payout Ratio | |||||||||||||||||
Dividends per common share | $ | 0.68 | $ | 0.68 | $ | 2.04 | $ | 2.02 | |||||||||
FFO per diluted share | $ | 0.53 | $ | 0.85 | $ | 2.11 | $ | 2.50 | |||||||||
FFO payout ratio | 128 | % | 80 | % | 97 | % | 81 | % | |||||||||
FFO Payout Ratio - Normalized | |||||||||||||||||
Dividends per share | $ | 0.68 | $ | 0.68 | $ | 2.04 | $ | 2.02 | |||||||||
FFO per diluted share - normalized | $ | 0.77 | $ | 0.86 | $ | 2.38 | $ | 2.51 | |||||||||
FFO payout ratio - normalized | 88 | % | 79 | % | 86 | % | 80 | % |
Notes: (1) |
Depreciation and amortization includes depreciation and amortization from discontinued operations. |
|
Funds Available For Distribution Reconciliation |
||||||||
(Amounts in 000's except per share data) | ||||||||
Three Months Ended | Nine Months Ended | |||||||
September 30, | September 30, | |||||||
2009 | 2008 | 2009 | 2008 | |||||
Net income attributable to common stockholders | $ 19,130 | $ 53,589 | $ 139,489 | $ 238,248 | ||||
Depreciation and amortization (1) | 41,085 | 41,690 | 123,143 | 120,894 | ||||
Loss (gain) on sales of properties | 806 | (12,619) | (26,907) | (130,813) | ||||
Noncontrolling interests | (17) | (9) | (49) | (26) | ||||
Gross straight-line rental income | (4,571) | (5,437) | (14,499) | (15,807) | ||||
Prepaid/straight-line rent receipts | 8,319 | 4,781 | 23,463 | 15,679 | ||||
Amortization related to above/(below) market leases, net | (620) | (214) | (1,344) | (676) | ||||
Non-cash interest expense | 2,895 | 2,774 | 8,511 | 8,332 | ||||
Cap-ex, tenant improvements, lease commissions | (3,637) | (1,555) | (8,795) | (3,482) | ||||
Funds available for distribution | 63,390 | 83,000 | 243,012 | 232,349 | ||||
Impairment of assets | 1,873 | 0 | 1,873 | 0 | ||||
Realized loss on derivatives | 0 | 1,513 | 0 | 1,513 | ||||
Non-recurring G&A expenses | 0 | 0 | 3,909 | 0 | ||||
Loss (gain) on extinguishment of debt | 26,374 | (768) | 24,697 | (2,094) | ||||
Provision for loan losses | 0 | 0 | 140 | 0 | ||||
Non-recurring income tax expense | 0 | 0 | 0 | 1,325 | ||||
Prepaid/straight-line rent receipts | (8,319) | (4,781) | (23,463) | (15,679) | ||||
Funds available for distribution - normalized | $ 83,318 | $ 78,964 | $ 250,168 | $ 217,414 | ||||
Average common shares outstanding: | ||||||||
Basic | 114,874 | 96,040 | 111,345 | 90,500 | ||||
Diluted | 115,289 | 96,849 | 111,749 | 91,121 | ||||
Per share data: | ||||||||
Net income attributable to common stockholders | ||||||||
Basic | $ 0.17 | $ 0.56 | $ 1.25 | $ 2.63 | ||||
Diluted | 0.17 | 0.55 | 1.25 | 2.61 | ||||
Funds available for distribution | ||||||||
Basic | $ 0.55 | $ 0.86 | $ 2.18 | $ 2.57 | ||||
Diluted | 0.55 | 0.86 | 2.17 | 2.55 | ||||
Funds available for distribution - normalized | ||||||||
Basic | $ 0.73 | $ 0.82 | $ 2.25 | $ 2.40 | ||||
Diluted | 0.72 | 0.82 | 2.24 | 2.39 | ||||
FAD Payout Ratio | ||||||||
Dividends per common share | $ 0.68 | $ 0.68 | $ 2.04 | $ 2.02 | ||||
FAD per diluted share | $ 0.55 | $ 0.86 | $ 2.17 | $ 2.55 | ||||
FAD payout ratio | 124% | 79% | 94% | 79% | ||||
FAD Payout Ratio - Normalized | ||||||||
Dividends per common share | $ 0.68 | $ 0.68 | $ 2.04 | $ 2.02 | ||||
FAD per diluted share - normalized | $ 0.72 | $ 0.82 | $ 2.24 | $ 2.39 | ||||
FAD payout ratio - normalized | 94% | 83% | 91% | 85% |
Notes: (1) |
Depreciation and amortization includes depreciation and amortization from discontinued operations. |
|
Outlook Reconciliations |
|||||||||
(Amounts in 000's except per share data) | |||||||||
Prior Outlook | Current Outlook | ||||||||
Year Ended | Year Ended | ||||||||
December 31, 2009 | December 31, 2009 | ||||||||
Low | High | Low | High | ||||||
FFO Reconciliation: |
|||||||||
Net income attributable to common stockholders | $ 199,842 | $ 207,592 | $ 185,038 | $ 187,288 | |||||
Loss (gain) on sales of properties | (27,713) | (27,713) | (26,907) | (26,907) | |||||
Depreciation and amortization (1) | 170,000 | 170,000 | 167,000 | 167,000 | |||||
Funds from operations | 342,129 | 349,879 | 325,131 | 327,381 | |||||
Loss (gain) on extinguishment of debt | 3,822 | 3,822 | 24,697 | 24,697 | |||||
Impairment of assets | 0 | 0 | 1,873 | 1,873 | |||||
Provision for loan losses | 140 | 140 | 140 | 140 | |||||
Non-recurring G&A expenses (2) | 3,909 | 3,909 | 3,909 | 3,909 | |||||
Funds from operations - normalized | $ 350,000 | $ 357,750 | $ 355,750 | $ 358,000 | |||||
Per share data (diluted): | |||||||||
Net income attributable to common stockholders | $ 1.75 | $ 1.82 | $ 1.61 | $ 1.63 | |||||
Funds from operations | 3.00 | 3.07 | 2.83 | 2.85 | |||||
Funds from operations - normalized | 3.07 | 3.14 | 3.10 | 3.12 | |||||
FAD Reconciliation: |
|||||||||
Net income attributable to common stockholders | $ 199,842 | $ 207,592 | $ 185,038 | $ 187,288 | |||||
Loss (gain) on sales of properties | (27,713) | (27,713) | (26,907) | (26,907) | |||||
Depreciation and amortization (1) | 170,000 | 170,000 | 167,000 | 167,000 | |||||
Gross straight-line rental income | (18,000) | (18,000) | (18,800) | (18,800) | |||||
Prepaid/straight-line rent receipts | 15,144 | 15,144 | 23,463 | 23,463 | |||||
Amortization related to above/(below) market leases, net |
(1,300) | (1,300) | (1,750) | (1,750) | |||||
Non-cash interest expense | 11,550 | 11,550 | 11,550 | 11,550 | |||||
Cap-ex, tenant improvements, lease commissions | (10,000) | (10,000) | (11,500) | (11,500) | |||||
Funds available for distribution | 339,523 | 347,273 | 328,094 | 330,344 | |||||
Loss (gain) on extinguishment of debt | 3,822 | 3,822 | 24,697 | 24,697 | |||||
Impairment of assets | 0 | 0 | 1,873 | 1,873 | |||||
Provision for loan losses | 140 | 140 | 140 | 140 | |||||
Non-recurring G&A expenses (2) | 3,909 | 3,909 | 3,909 | 3,909 | |||||
Prepaid/straight-line rent receipts | (15,144) | (15,144) | (23,463) | (23,463) | |||||
Funds available for distribution - normalized | $ 332,250 | $ 340,000 | $ 335,250 | $ 337,500 | |||||
Per share data (diluted): | |||||||||
Net income attributable to common stockholders | $ 1.75 | $ 1.82 | $ 1.61 | $ 1.63 | |||||
Funds available for distribution | 2.98 | 3.05 | 2.86 | 2.88 | |||||
Funds available for distribution - normalized | 2.91 | 2.98 | 2.92 | 2.94 |
Notes: |
(1) |
Depreciation and amortization includes depreciation and amortization from discontinued operations. |
|
(2) |
Expenses recognized in connection with the departure of Raymond Braun. |
Source:
Health Care REIT, Inc.
Scott Estes, 419-247-2800
Mike Crabtree, 419-247-2800